MCB 3020L Lecture Notes - Lecture 31: Muromonab-Cd3, Anticoagulant, Transplant Rejection
Document Summary
Factor vii treamtent of hemorrhagic strokes; produced by mammalian cell culture. Treament of hemophilia,; improves clotting; produced by mammalian cell culture. Therapy for leukemia, melanom and hepatitis produced by e. coli and s. cerevisiae. Treatment ofr multiple sclerosis; produced by mammalian cell culture. Treatment of hcronic granulomatous disease; produced by e. coli. Produced y s. cerevisiae that carries hepatitis-virus gene on a plasmid. Corrects growth deficiencies in children; produced by e. coli. Therapy for diabetes; better tolerated than insulin extracted from animals; made by e. coli influenza vaccine. Trial vaccine made from e. coli s. cerevisiae carrying virus genes. Regulate the immune system; possible treatment for cancer; made by e. coli. Possible therapy for cancer and transplant rejection; used in diagnostic tests; produced by mammalian cell culture (from fusion of cancer cell and antibody-producing cell) Monoclonal antibody used in transplatn apatients to help suppress the immune system, reducing the chance of tissue rejection; produced by mouse cells. Anticoagulant; therapy for heart attacks; produced by e. coli and yeast.
